Greatmark Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
20,071
+491
+3% +$45.1K 0.21% 66
2025
Q4
$1.76M Sell
19,580
-2,780
-12% -$264K 0.21% 67
2025
Q3
$2.2M Buy
22,360
+820
+4% +$81.3K 0.26% 60
2025
Q2
$1.96M Buy
21,540
+825
+4% +$79.8K 0.25% 65
2025
Q1
$2.34M Buy
20,715
+1,340
+7% +$143K 0.32% 53
2024
Q4
$2.05M Sell
19,375
-1,450
-7% -$156K 0.28% 56
2024
Q3
$2.25M Buy
20,825
+4,265
+26% +$465K 0.3% 56
2024
Q2
$1.8M Buy
16,560
+385
+2% +$45.4K 0.26% 59
2024
Q1
$2.13M Buy
16,175
+1,435
+10% +$179K 0.3% 58
2023
Q4
$1.79M Buy
14,740
+930
+7% +$104K 0.28% 54
2023
Q3
$1.55M Buy
13,810
+365
+3% +$46.4K 0.27% 55
2023
Q2
$1.96M Buy
13,445
+7,540
+128% +$1.02M 0.33% 56
2023
Q1
$763K Sell
5,905
-50
-0.8% -$6.28K 0.14% 79
2022
Q4
$759K Buy
5,955
+640
+12% +$74.3K 0.14% 76
2022
Q3
$556K Hold
5,315
0.11% 83
2022
Q2
$558K Buy
5,315
+3,175
+148% +$377K 0.11% 86
2022
Q1
$274K Buy
+2,140
New +$258K 0.05% 120

Other funds holding ZBH

Greatmark Investment Partners's ZBH Position: Q1 2026 in Review

Greatmark Investment Partners increased its Zimmer Biomet (ZBH) stake by 2.5% in Q1 2026, buying an estimated $45.1K and bringing the position to 20,071 shares worth $1.81M. The position accounts for 0.21% of the portfolio, ranked #66.

Greatmark Investment Partners first reported a position in ZBH in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.34M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Greatmark Investment Partners held 20,071 shares of Zimmer Biomet worth $1.81M as of Q1 2026.
  • Greatmark Investment Partners bought 491 Zimmer Biomet shares in Q1 2026, an estimated $45.1K.
  • Zimmer Biomet made up 0.21% of Greatmark Investment Partners's portfolio in Q1 2026, its #66 holding.
  • Greatmark Investment Partners first reported a position in Zimmer Biomet in Q1 2022 and has held it in 17 quarters since.
  • Greatmark Investment Partners's Zimmer Biomet position peaked at $2.34M in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Greatmark Investment Partners's 13F filing for Q1 2026, filed 28 Apr 2026.